Critical review of mouse models of venous thrombosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 3, 2012, Pages 556-562

  Diaz, Jose A ^a   Obi, Andrea T ^a   Myers, Daniel D ^a,b   Wrobleski, Shirley K ^a   Henke, Peter K ^a   MacKman, Nigel ^c   Wakefield, Thomas W ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

animal models; mouse; thrombosis; vascular biology; venous thrombosis

Indexed keywords

FERRIC CHLORIDE; PADGEM PROTEIN;

ANIMAL MODEL; DEEP VEIN THROMBOSIS; GENE DELETION; GENE SEQUENCE; GENETIC DISORDER; INFERIOR CAVA VEIN; INFERIOR CAVA VEIN OBSTRUCTION; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LUNG EMBOLISM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOGENESIS; THROMBUS; TRANSGENIC MOUSE; VEIN LIGATION; VEIN THROMBOSIS; VEIN WALL;

EID: 84857610861     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.244608     Document Type: Review

References (55)

1. Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH. Surveillance for deep vein thrombosis and pulmonary embolism: Recommendations from a national workshop. Am J Prev Med. 2010;38:S502-S509.
2. Wakefield TW, McLafferty RB, Lohr JM, Caprini JA, Gillespie DL, Passman MA. Call to action to prevent venous thromboembolism. J Vasc Surg. 2009;49:1620-1623.
3. Virchow R. Thrombosis and emboli. Canton, MA: Science History Publications, 1846.
4. Jeske WP, Iqbal O, Fareed J, Kaiser B. A survey of venous thrombosis models. Methods Mol Med. 2004;93:221-237.
5. Didisheim P. Animal models useful in the study of thrombosis and antithrombotic agents. Prog Hemost Thromb. 1972;1:165-197.
6. Ginsburg D. Identifying novel genetic determinants of hemostatic balance. J Thromb Haemost. 2005;3:1561-1568. (Pubitemid 41716540)
7. Sands AT. The master mammal. Nat Biotechnol. 2003;21:31-32. (Pubitemid 36055820)
8. Myers D Jr, Farris D, Hawley A, Wrobleski S, Chapman A, Stoolman L, Knibbs R, Strieter R, Wakefield T. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res. 2002;108:212-221. (Pubitemid 36062701)
9. Henke PK, Mitsuya M, Luke CE, Elfline MA, Baldwin JF, Deatrick KB, Diaz JA, Sood V, Upchurch GR, Wakefield TW, Hogaboam C, Kunkel SL. Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol. 2011;31: 43-49.
10. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008;28: 387-391.
11. Espinola RG, Liu X, Colden-Stanfield M, Hall J, Harris EN, Pierangeli SS. E-selectin mediates pathogenic effects of antiphospholipid antibodies. J Thromb Haemost. 2003;1:843-848.
12. Leadley RJ Jr, Chi L, Rebello SS, Gagnon A. Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. J Pharmacol Toxicol Methods. 2000;43:101-116. (Pubitemid 32057032)
13. Matsuo O, Rijken DC, Collen D. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature. 1981;291:590-591. (Pubitemid 11043684)
14. Leadley RJ Jr, Kasiewski CJ, Bostwick JS, Bentley R, Dunwiddie CT, Perrone MH. Inhibition of repetitive thrombus formation in the stenosed canine coronary artery by enoxaparin, but not by unfractionated heparin. Arterioscler Thromb Vasc Biol. 1998;18:908-914. (Pubitemid 28272584)
15. Agnelli G, Pascucci C, Cosmi B, Nenci GG. The comparative effects of recombinant hirudin (cgp 39393) and standard heparin on thrombus growth in rabbits. Thromb Haemost. 1990;63:204-207. (Pubitemid 20128182)
16. Fitzgerald DJ, Fitzgerald GA. Role of thrombin and thromboxane a2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci USA. 1989;86:7585-7589. (Pubitemid 19254501)
17. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg. 2003;38:1075-1089. (Pubitemid 37409646)
18. Ramacciotti E, Myers DD Jr, Wrobleski SK, Deatrick KB, Londy FJ, Rectenwald JE, Henke PK, Schaub RG, Wakefield TW. P-selectin/PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis. Thromb Res. 2010;125:e138-e142.
19. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL, Greenfield LJ. Venous thrombosisassociated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol. 1995; 15:258-268.
20. Wojcik BM, Wrobleski SK, Hawley AE, Wakefield TW, Myers DD Jr, Diaz JA. Interleukin-6: A potential target for post-thrombotic syndrome. Ann Vasc Surg. 2011;25:229-239.
21. Henke PK, Varga A, De S, Deatrick CB, Eliason J, Arenberg DA, Sukheepod P, Thanaporn P, Kunkel SL, Upchurch GR Jr, Wakefield TW. Deep vein thrombosis resolution is modulated by monocyte cxcr2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol. 2004;24:1130-1137. (Pubitemid 38737842)
22. Brill A, Fuchs TA, Chauhan AK, Yang JJ, De Meyer SF, Kollnberger M, Wakefield TW, Lammle B, Massberg S, Wagner DD. Von willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 2011;117:1400-1407.
23. Diaz JA, Ballard-Lipka NE, Farris DM, Hawley AE, Wrobleski SK, Myers DD, Henke PK, Lawrence DA, Wakefield TW. Impaired fibrinolytic system in apoe gene-deleted mice with hyperlipidemia augments deep vein thrombosis [epub ahead of print Nov. 23]. J Vasc Surg. 2011.
24. Humphries J, Gossage JA, Modarai B, Burnand KG, Sisson TH, Murdoch C, Smith A. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis. J Vasc Surg. 2009;50:1127-1134.
25. Myers DD Jr, Rectenwald JE, Bedard PW, Kaila N, Shaw GD, Schaub RG, Farris DM, Hawley AE, Wrobleski SK, Henke PK, Wakefield TW. Decreased venous thrombosis with an oral inhibitor of p selectin. J Vasc Surg. 2005;42:329-336. (Pubitemid 41139242)
26. Pierangeli SS, Harris EN. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus. 1994;3:247-251. (Pubitemid 24277035)
27. Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD. Platelets adhere to and translocate on von willebrand factor presented by endothelium in stimulated veins. Blood. 2000;96: 3322-3328.
28. Chauhan AK, Kisucka J, Lamb CB, Bergmeier W, Wagner DD. Von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins. Blood. 2007;109:2424-2429. (Pubitemid 46425884)
29. Chauhan AK, Motto DG, Lamb CB, Bergmeier W, Dockal M, Plaimauer B, Scheiflinger F, Ginsburg D, Wagner DD. Systemic antithrombotic effects of adamts13. J Exp Med. 2006;203:767-776.
30. Bonnefoy A, Daenens K, Feys HB, De Vos R, Vandervoort P, Vermylen J, Lawler J, Hoylaerts MF. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial vwf from cleavage by adamts13. Blood. 2006;107:955-964. (Pubitemid 43156292)
31. Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood. 2000;95:577-580. (Pubitemid 30041672)
32. Day SM, Reeve JL, Myers DD, Fay WP. Murine thrombosis models. Thromb Haemost. 2004;92:486-494. (Pubitemid 39248005)
33. Farrehi PM, Ozaki CK, Carmeliet P, Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation. 1998;97:1002-1008. (Pubitemid 28125473)
34. Carmeliet P, Moons L, Stassen JM, De Mol M, Bouche A, van den Oord JJ, Kockx M, Collen D. Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol. 1997;150: 761-776. (Pubitemid 27073802)
35. Rumbaut RE, Bellera RV, Randhawa JK, Shrimpton CN, Dasgupta SK, Dong JF, Burns AR. Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a tlr4-dependent, neutrophil-independent mechanism. Am J Physiol Heart Circ Physiol. 2006;290:H1671-H1679.
36. Rumbaut RE, Randhawa JK, Smith CW, Burns AR. Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, cd18, icam-1, or p-selectin. Microcirculation. 2004;11: 239-247. (Pubitemid 39618612)
37. Rumbaut RE, Slaff DW, Burns AR. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation. 2005;12:259-274. (Pubitemid 40691823)
38. Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial p-selectin. Proc Natl Acad Sci USA. 1995;92:7450-7454.
39. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res. 1990;60:269-280.
40. Buyue Y, Whinna HC, Sheehan JP. The heparin-binding exosite of factor IXA is a critical regulator of plasma thrombin generation and venous thrombosis. Blood. 2008;112:3234-3241.
41. Yang M, Kirley TL. Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo. Thromb Res. 2008;122:541-548.
42. Zhou J, May L, Liao P, Gross PL, Weitz JI. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol. 2009;29:863-869.
43. Singh I, Burnand KG, Collins M, Luttun A, Collen D, Boelhouwer B, Smith A. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation. 2003;107:869-875. (Pubitemid 36241046)
44. Singh I, Smith A, Vanzieleghem B, Collen D, Burnand K, Saint-Remy JM, Jacquemin M. Antithrombotic effects of controlled inhibition of factor viii with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood. 2002;99:3235-3240. (Pubitemid 34525303)
45. Burnand KG, Gaffney PJ, McGuinness CL, Humphries J, Quarmby JW, Smith A. The role of the monocyte in the generation and dissolution of arterial and venous thrombi. Cardiovasc Surg. 1998;6:119-125. (Pubitemid 28202240)
46. Diaz JA, Hawley AE, Alvarado CM, Berguer AM, Baker NK, Wrobleski SK, Wakefield TW, Lucchesi BR, Myers DD Jr. Thrombogenesis with continuous blood flow in the inferior vena cava: a novel mouse model. Thromb Haemost. 2010;104:366-375.
47. Cooley BC, Szema L, Chen CY, Schwab JP, Schmeling G. A murine model of deep vein thrombosis: characterization and validation in transgenic mice. Thromb Haemost. 2005;94:498-503. (Pubitemid 41300842)
48. Cooley BC. In vivo fluorescence imaging of large-vessel thrombosis in mice. Arterioscler Thromb Vasc Biol. 2011;31:1351-1356.
49. Alvarado CM, Diaz JA, Hawley AE, Wrobleski SK, Sigler RE, Myers DD Jr. Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis. Thromb Res. 2011;127:478-486.
50. Diaz JA, Wrobleski SK, Hawley AE, Lucchesi BR, Wakefield TW, Myers DD Jr. Electrolytic inferior vena cava model (EIM) of venous thrombosis. J Vis Exp. 2011;53:2737.
51. Myers DD Jr, Schaub R, Wrobleski SK, Londy FJ III, Fex BA, Chapman AM, Greenfield LJ, Wakefield TW. P-selectin antagonism causes dosedependent venous thrombosis inhibition. Thromb Haemost. 2001;85: 423-429. (Pubitemid 32233012)
52. Meier TR, Myers DD Jr, Wrobleski SK, Zajkowski PJ, Hawley AE, Bedard PW, Ballard NE, Londy FJ, Kaila N, Vlasuk GP, Schaub RG, Wakefield TW. Prophylactic p-selectin inhibition with psi-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost. 2008;99:343-351. (Pubitemid 351230965)
53. Myers DD Jr, Wrobleski SK, Longo C, Bedard PW, Kaila N, Shaw GD, Londy FJ, Rohrer SE, Fex BA, Zajkowski PJ, Meier TR, Hawley AE, Farris DM, Ballard NE, Henke PK, Schaub RG, Wakefield TW. Resolution of venous thrombosis using a novel oral small-molecule inhibitor of p-selectin (psi-697) without anticoagulation. Thromb Haemost. 2007; 97:400-407. (Pubitemid 46437802)
54. Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin MS, Kadell AM, Wilke CA, Brown SL, Wrobleski SK, Burdick MD, Anderson DC, Greenfield LJ. Anti-p-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg. 1997;25:816-827; discussion 828.
55. Myers DD Jr, Henke PK, Bedard PW, Wrobleski SK, Kaila N, Shaw G, Meier TR, Hawley AE, Schaub RG, Wakefield TW. Treatment with an oral small molecule inhibitor of p selectin (psi-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg. 2006; 44:625-632. (Pubitemid 44293198)